Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8312 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8312 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8312 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8288 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8235 |
Intermediate Similarity |
NPD3705 |
Approved |
0.8217 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8205 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8188 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8156 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8117 |
Intermediate Similarity |
NPD37 |
Approved |
0.8075 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8015 |
Intermediate Similarity |
NPD1357 |
Approved |
0.8 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7986 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7887 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7836 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7808 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7763 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.774 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7721 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7714 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7708 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7708 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.763 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7628 |
Intermediate Similarity |
NPD1653 |
Approved |
0.761 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7603 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7545 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7534 |
Intermediate Similarity |
NPD7095 |
Approved |
0.75 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD2978 |
Approved |
0.75 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7485 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7463 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7452 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7447 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD5846 |
Approved |
0.744 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7439 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7434 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7431 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7426 |
Intermediate Similarity |
NPD228 |
Approved |
0.7417 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7403 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7383 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7365 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7355 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7351 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7351 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7351 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7338 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7329 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7326 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7324 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7315 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7285 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7285 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7279 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7279 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7253 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7215 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7193 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7178 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7178 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7172 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7133 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7123 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7122 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7115 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7115 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7114 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7092 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7081 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7081 |
Intermediate Similarity |
NPD4210 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7069 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7063 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7063 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD52 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD7037 |
Approved |
0.703 |
Intermediate Similarity |
NPD2560 |
Approved |
0.703 |
Intermediate Similarity |
NPD2563 |
Approved |
0.703 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7007 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7007 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD290 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7 |
Intermediate Similarity |
NPD27 |
Approved |
0.6994 |
Remote Similarity |
NPD7007 |
Discovery |
0.6993 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6993 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6988 |
Remote Similarity |
NPD3882 |
Suspended |
0.6987 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6987 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6987 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6987 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD3092 |
Approved |
0.6982 |
Remote Similarity |
NPD6071 |
Discontinued |
0.6982 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6977 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD2801 |
Approved |
0.6968 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6964 |
Remote Similarity |
NPD5494 |
Approved |
0.6959 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6959 |
Remote Similarity |
NPD6696 |
Suspended |
0.6954 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6946 |
Remote Similarity |
NPD5604 |
Discontinued |
0.6946 |
Remote Similarity |
NPD7831 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD7833 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.6934 |
Remote Similarity |
NPD968 |
Approved |
0.6928 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD7549 |
Discontinued |
0.691 |
Remote Similarity |
NPD7906 |
Approved |
0.6909 |
Remote Similarity |
NPD3383 |
Approved |
0.6909 |
Remote Similarity |
NPD3384 |
Approved |
0.6909 |
Remote Similarity |
NPD3382 |
Approved |
0.6908 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD5110 |
Phase 2 |
0.6908 |
Remote Similarity |
NPD5109 |
Approved |
0.6908 |
Remote Similarity |
NPD5111 |
Phase 2 |
0.6906
|
Remote Similarity |
NPD5451 |
Approved |